Artemis Therapeutics Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was USD 0.061283 million compared to USD 0.003377 million a year ago. Net loss was USD 0.201396 million compared to USD 0.045874 million a year ago. Basic loss per share from continuing operations was USD 0.0021 compared to USD 0.0006 a year ago.
For the six months, sales was USD 0.07766 million compared to USD 0.003377 million a year ago. Net loss was USD 0.404681 million compared to USD 0.078667 million a year ago. Basic loss per share from continuing operations was USD 0.0041 compared to USD 0.001 a year ago.